Sunday, June 29, 2025 6/29/2025

Methods for Mapping Genetic Regulatory Elements in Single Cells and Single Molecules

Award Number: R01HG012383
ORGANIZATION: NATIONAL HUMAN GENOME RESEARCH INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2022
PERIOD OF PERFORMANCE END DATE: 04/30/2026

Group Awards By:

View Award Description

Methods for Mapping Genetic Regulatory Elements in Single Cells and Single Molecules - PROJECT SUMMARY The human genome is regulated through interactions between DNA and proteins in the nucleus that define and maintain the epigenetic state of cells. Therefore, large consortia such as the Encyclopedia of DNA Elements (ENCODE) are dedicated to comprehensively mapping regulatory elements such as transcription factor binding or histone modification so that we may understand regulatory processes that guide development, disease, and the everyday functioning of cells in our body. However, current methods for genome-wide measurement of protein-DNA interactions are unable to map regulatory elements in highly repetitive regions of the genome because they rely on high-throughput, short-read DNA sequencing platforms. This limitation prohibits comprehensive investigation of roughly 8% of the human genome including centromeres and ribosomal DNA arrays, which play essential roles in chromosome segregation and nuclear organization. Furthermore, these methods typically lack the sensitivity to profile the epigenetic landscape of single cells, preventing high-resolution measurements of regulatory variation in complex tissues. The goal of this research program is to expand the toolbox for mapping protein-DNA interactions genome-wide and extend capabilities to long-read sequencing and single-cell sequencing technologies with the development of two methods: (1) Directed methylation and long- read sequencing (DiMeLo-Seq) and (2) single-cell directed methylation and sequencing (scDiMe-Seq). To record the genomic position of protein binding or histone modification, a methyltransferase fused to protein A will be directed to the targeted regulatory element with a primary antibody. Upon activation, the methyltransferase will methylate adenines in proximal DNA sequences. DiMeLo-Seq will implement long-read DNA sequencing technologies such as nanopore sequencing to directly detect the position of these modifications on long molecules of DNA, taking advantage of the differential signal generated by methyl-adenines as they pass through the nanopore. This approach will produce sequencing reads of up to hundreds of kilobases long, providing high- confidence mapping of regulatory elements to regions of the genome that are unmappable with short-read sequencing. To detect these modifications with single-cell sensitivity, scDiMe-Seq will enrich genomic loci containing methyl adenines through targeted digestion, adapter ligation, and PCR amplification. These enriched fragments will then be sequenced using standard high-throughput sequencing. This project aims to develop DiMeLo-Seq and scDiMe-Seq through rigorous protocol optimization of the directed methylation strategy and sequencing library preparation for long and short-read sequencing. The methods will then be characterized and validated by targeting well studied features such as lamina associated domains, and CTCF landscapes, as well as H3K9me3 and CENPA which are both enriched in centromeres. The overall goal of this project is to produce two robust and scalable methods that may shed light on regulatory mechanism in previously unexplored regions of the genome and aid in Human Cell Atlas initiatives by providing epigenetic information for single-cell analysis.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $446,742 )
2025	2025	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Human Genome Research	000	4	6/10/2025	NON-COMPETING CONTINUATION	$446,742
														Subtotal = $446,742

Issue Date FY: 2024 ( Subtotal = $433,371 )
2024	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Human Genome Research	001	3	6/17/2024	NON-COMPETING CONTINUATION	$35,376
2024	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Human Genome Research	000	3	5/3/2024	NON-COMPETING CONTINUATION	$397,995
														Subtotal = $433,371

Issue Date FY: 2023 ( Subtotal = $429,241 )
2023	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Human Genome Research	000	2	4/28/2023	NON-COMPETING CONTINUATION	$429,241
														Subtotal = $429,241

Issue Date FY: 2022 ( Subtotal = $489,151 )
2022	2022	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Human Genome Research	000	1	7/1/2022	NEW	$489,151
														Subtotal = $489,151

Grand Total All Awards = $1,798,505

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Methods for Mapping Genetic Regulatory Elements in Single Cells and Single Molecules

Award Number: R01HG012383

ORGANIZATION: NATIONAL HUMAN GENOME RESEARCH INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2022

PERIOD OF PERFORMANCE END DATE: 04/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer